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ABSTRACT 
Neuropsychological research on adults with attention deficit hyperactivity disorder (ADHD) 
revealed considerable impairments in memory functions related to executive control. However, 
only limited evidence exists supporting the effects of pharmacological treatment using 
methylphenidate (MPH) on memory functions. The aim of the present study was, therefore, to 
explore the impact of MPH on various memory functions of adults with ADHD. Thirty-one adults 
with ADHD treated with MPH, 36 adults with ADHD not-treated with MPH, and 36 healthy 
individuals were assessed on several aspects of memory, including short-term memory, working 
memory, retrospective memory, prospective memory, and source memory. Multivariate statistical 
analyses were applied to compare memory functions between groups. Nonmedicated adults with 
ADHD showed considerable impairments in memory functions related to executive control. Adults 
with ADHD treated with MPH showed improved memory functions when compared to 
nonmedicated patients, but were still impaired when compared to healthy controls. The present 
study emphasized the severity of memory impairments of adults with ADHD. A pharmacological 
treatment with MPH appeared to improve memory, but does not normalize functioning. Additional 
treatment intervention (e.g., cognitive-behavioral therapy) is therefore necessary. 
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ADHD in adulthood is strongly associated with 
academic and occupational failure, social dysfunction, 
low self-esteem, and reduced quality of life (Agarwal, 
Goldenberg, Perry, & IsHak, 2012; Biederman, 2005; 
Canu & Carlson, 2007; Canu, Newman, Morrow, & 
Pope, 2008; Mueller, Fuermaier, Koerts, & Tucha, 
2012). A clinical evaluation of symptoms and impair-
ments of patients with ADHD benefits from an objec-
tive assessment of neuropsychological functions using 
standardized psychometric tests. Most theories on 
neuropsychological functions of adults with ADHD 
proposed a primary deficit of inhibitory executive 
functions (Barkley, 1997; Castellanos, Sonuga-Barke, 
Milham, & Tannock, 2006; Tannock, 1998) which 
resulted in a large body of research examining various 
functions associated with executive control, including 
focused attention, divided attention, vigilance, work-
ing memory, inhibition, set-shifting, verbal fluency, 
and problem solving (Boonstra, Kooij, Oosterlaan, 
Sergeant, & Buitelaar, 2010; Boonstra, Oosterlaan, 
Sergeant, & Buitelaar, 2005; Dinn, Robbins, & Harris, 
2011; Fuermaier et al., 2015; Hervey, Epstein, & 
Curry, 2004; Lange et al., 2014; Schoechlin & Engel, 
2005; O. Tucha et al., 2005, L. Tucha et al., 2008, 
2009). 
More recently, theoretical considerations and 
empirical research suggested that executive dysfunc-
tions of adults with ADHD might also adversely affect 
memory functions of patients (Altgassen, Koch, & 
Kliegel, 2014; Altgassen, Kretschmer, & Kliegel, 2014; 
Fuermaier, Tucha, Koerts, Aschenbrenner, Weisbrod, 
et al., 2013; Fuermaier et al., 2014, 2015; Fuermaier, 
Tucha, Koerts, Aschenbrenner, Westermann, et al., 
2013; Muir-Broaddus, Rosenstein, Medina, & 
Soderberg, 2002; Pollak, Kahana-Vax, & Hoofien, 
2008; Seidman, Biederman, Weber, Hatch, & Faraone, 
1998). For example, adults with ADHD have been 
shown to suffer from deficits of both the encoding 
of new information as well as the recall of stored infor-
mation, whereas the retention of learned information 
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was found to be unimpaired (forgetting rate compara-
ble to normal functioning level; Fuermaier, Tucha, 
Koerts, Aschenbrenner, Weisbrod, et al., 2013; Kaplan, 
Dewey, Crawford, & Fisher, 1998; Muir-Broaddus et 
al., 2002; Pollak et al., 2008; Seidman et al., 1998). 
Efficient encoding and recall processes (i.e., free recall) 
were both attributed to intact executive functions, 
including semantic clustering, effortful rehearsal, 
strategic use of mnemonics, and careful consideration 
of response alternatives (Pollak et al., 2008). Retention 
of learned information, however, does not primarily 
depend on these cognitive processes. Furthermore, 
adults with ADHD were demonstrated to have deficits 
in source memory (Fuermaier, Tucha, Koerts, Aschen-
brenner, Weisbrod, et al., 2013; White & Marks, 2004) 
and prospective memory (Altgassen, Koch, et al., 2014; 
Altgassen, Kretschmer, et al., 2014; Fuermaier, Tucha, 
Koerts, Aschenbrenner, Westermann, et al., 2013), two 
memory components which were stressed to require 
high demands on executive control (Glisky, Polster, 
& Routhieaux, 1995; Kliegel, McDaniel, & Einstein, 
2000). Source memory comprises information where 
and when an event took place and how it was acquired, 
causing biographic events to become vivid and rich 
(Drag, Bieliauskas, Kaszniak, Bohnen, & Glisky, 
2009). Prospective memory can be defined as the per-
formance of an intended action at a particular point in 
the future, such as taking prescribed medication or 
keeping an appointment. Prospective memory was 
stressed by several authors to be an essential cognitive 
ability for successful social and occupational function-
ing (Crovitz & Daniel, 1984; Kliegel & Martin, 2003; 
Terry, 1988). 
The impairments of cognition associated with 
ADHD emphasize the need for an effective treatment. 
First-line choice of treatment is often a pharmacological 
treatment using stimulants, that is, methylphenidate 
(MPH; Vidal-Estrada, Bosch-Munso, Nogueira-Morais, 
Casas-Brugue, & Ramos-Quiroga, 2012; S. B. Wigal, 
2009; T. Wigal et al., 1999). A large number of studies 
on adults with ADHD reported positive effects of 
MPH on several aspects of cognition, including alert-
ness, vigilance, selective attention, divided attention, 
working memory, response inhibition, and flexibility 
(Aron, Dowson, Sahakian, & Robbins, 2003; Coghill 
et al., 2013; O. Tucha, Mecklinger et al., 2006, L. Tucha 
et al., 2011; Turner, Blackwell, Dowson, McLean, & 
Sahakian, 2005). However, considerably less evidence 
exists presenting the effects of MPH on memory func-
tions of adults with ADHD. For example, there are only 
two studies available showing that MPH significantly 
improves free recall of learned information of adults 
with ADHD (Riordan et al., 1999; Verster et al., 
2010). The effect of MPH on other aspects of memory 
of adults with ADHD, such as prospective memory or 
source memory, is still unknown. In this respect, it 
might be of interest that numerous studies did not only 
demonstrate that children and adolescents with ADHD 
also display deficits in the above mentioned memory 
functions (e.g., Gau & Shang, 2010; Kataria, Hall, Wong, 
& Keys, 1992; Kerns & Price, 2001; Kingdon, Cardoso, 
& McGrath, 2015; Kliegel, Ropeter, & Mackinlay, 
2006; Martinussen, Hayden, Hogg-Johnson, & Tannock, 
2005; Muir-Broaddus et al., 2002; Willcutt, Doyle, Nigg, 
Faraone, & Pennington, 2005) but also that stimulant 
drug treatment has the potential to improve these func-
tions considerably (e.g., Bedard, Martinussen, Ickowicz, 
& Tannock, 2004; Mehta, Goodyer, & Sahakian, 2004; 
Rhodes, Coghill, & Matthews, 2005; Vance, Maruff, & 
Barnett, 2003). Furthermore, a recent review examining 
the impact of MPH on different domains of cognition of 
healthy individuals revealed that single doses of MPH 
enhance aspects of memory functioning (Linssen, 
Sambeth, Vuurman, & Riedel, 2013). While about two 
thirds of studies examining working memory and about 
one third of studies examining verbal learning and 
memory observed significant improvements following 
MPH intake, visual learning and memory has been 
found to be unaffected by single doses of MPH. 
The aim of the present study was, therefore, to exam-
ine the effect of MPH on memory functioning of adults 
with ADHD. A comprehensive assessment of several 
aspects of memory was performed on three groups of 
participants, that is, adults with ADHD treated with 
MPH, adults with ADHD not-treated with MPH, and 
healthy individuals. A basic test battery of attention 
was also administered to all participants in order to 
describe their level of cognition on routine neuropsy-
chological measures used for adults with ADHD. Given 
theoretical models describing ADHD as disorder of 
executive control (Barkley, 1997; Castellanos et al., 
2006), and based on previous research revealing 
memory impairments in adults with ADHD (e.g., 
Altgassen, Koch, et al., 2014; Fuermaier, Tucha, Koerts, 
Aschenbrenner, Weisbrod, et al., 2013; Fuermaier, 
Tucha, Koerts, Aschenbrenner, Westermann, et al., 
2013; Pollak et al., 2008; Seidman et al., 1998), it was 
expected that (a) adults with ADHD not-treated with 
MPH showed impaired memory functions when com-
pared to healthy individuals, with the largest effect sizes 
expected in memory functions which required high 
demands on executive control, i.e., free recall of infor-
mation (compared to word recognition), source mem-
ory and prospective memory. Furthermore, given the 
conclusive findings demonstrating that MPH effectively 
improves symptoms, cognition and functioning of 
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adults with ADHD (e.g., Coghill et al., 2013; 
Vidal-Estrada et al., 2012; S. B. Wigal, 2009), it was 
hypothesized that (b) adults with ADHD treated 
with MPH showed improved memory performance 
compared to patients not-treated with MPH. However, 
considering that MPH has been shown to improve 
cognition of adults with ADHD but did not normalize 
their level of performance (O. Tucha, Mecklinger 
et al., 2006, L. Tucha et al., 2011), it was expected that 
also adults with ADHD treated with MPH showed 
impaired memory functions when compared to healthy 
individuals. To the best of our knowledge, the present 
study was the first to explore the impact of stimulant 
drug treatments on various aspects of memory of adults 
with ADHD. The study has relevance and important 
implications for both research and clinical practice. 
Methods 
Participants 
Three groups of participants were recruited, that is, a 
group of adults with ADHD not-treated with MPH, 
a group of adults with ADHD treated with MPH 
and a group of healthy individuals. 
Patients with ADHD 
Patients were self-referred or referred from local 
psychiatrists or neurologists to the Department of 
Psychiatry and Psychotherapy, SRH Group, Karlsbad- 
Langensteinbach, Germany. A diagnostic assessment 
for ADHD in adulthood as well as a participation in 
the research project was offered to all participants. 
Diagnostic assessments were performed by experi-
enced clinicians and involved a clinical psychiatric 
interview according to DSM-IV criteria for ADHD as 
devised by Barkley and Murphy (1998) including the 
retrospective assessment of symptoms in childhood 
and current symptoms. Moreover, all participants 
completed two standardized self-report rating scales 
designed to quantify ADHD symptoms currently 
and retrospectively (Rösler, Retz-Junginger, Retz, & 
Stieglitz, 2008). Childhood ADHD symptoms were 
self-rated with the short version of the Wender Utah 
Rating Scale (WURS-K) including 25 items on a five- 
point scale (Ward, Wender, & Reimherr, 1993). Sever-
ity of ADHD symptoms in adulthood was self-rated 
with the ADHD Self-Report Scale consisting of 18 
items on a four-point scale corresponding to the diag-
nostic criteria of DSM-IV (American Psychiatric 
Association, 1994; Rösler et al., 2008). When parti-
cipants were asked to rate current symptom severity, 
patients with ADHD treated with MPH were 
instructed to refer to typical situations when not being 
treated with MPH and to rate the severity of experi-
enced ADHD symptoms in these situations. This 
approach was chosen to get an indication of self- 
reported symptom severity not affected by pharmaco-
logical treatment which can be compared between 
the two groups of patients (treated and not-treated 
with MPH). Intellectual functions of all participants 
were measured using the Multiple Choice Vocabulary 
Test (Lehrl, 1995). Patients were selected according 
to diagnosis, intellectual functions (IQ), and willing-
ness to participate in the study. Potential patients were 
excluded (a) if they had clinically significant or chronic 
medical conditions (e.g., recent operations, cardiac 
failure, kidney disease or Crohn’s disease), (b) if there 
was a history suggestive of ‘psychosis’ (indicating 
schizophrenia, delusional disorder, depressive disorder 
with psychotic features or manic episode), (c) if there 
was a history of neurological disorders including head 
injury, (d) if there was a history of substance abuse dis-
order during the previous two months, (e) if the initial 
psychiatric assessment indicated a current major 
depressive episode, or (f) if estimated premorbid verbal 
IQ was <85. In total, 67 adults with ADHD were 
recruited. Of the 67 adults with ADHD, 36 patients 
were not-treated with MPH and 31 patients were cur-
rently treated with MPH. Of the 36 adults with ADHD 
not-treated with MPH, 14 met DSM-IV criteria for 
ADHD – predominantly inattentive type (ADHD-I), 
one patient met criteria for ADHD – hyperactive- 
impulsive type (ADHD-H), and 21 patients met 
criteria for ADHD – combined type (ADHD-C). Seven 
patients were diagnosed with comorbid psychiatric 
disorders, including mood disorders (n ¼ 6) and per-
sonality disorder (n ¼ 1). All 31 patients with ADHD 
treated with MPH received individual tailored and 
clinical appropriate doses of MPH with a mean dose 
of 35.5 mg per day and with individual doses ranging 
from 10 to 80 mg per day. All patients were treated 
with MPH regularly on a daily basis. Seven of these 
patients met DSM-IV criteria for ADHD – predomi-
nantly inattentive type (ADHD-I), one patient met 
criteria for ADHD – hyperactive-impulsive type 
(ADHD-H), and 23 patients met criteria for ADHD 
– combined type (ADHD-C). Fourteen exhibited one 
or more comorbidities, including mood disorders 
(n ¼ 10), personality disorders (n ¼ 2), anxiety disor-
ders (n ¼ 3), somatoform disorders (n ¼ 2), obsessive- 
compulsive disorder (n ¼ 1), substance abuse in the 
past (n ¼ 1), and posttraumatic stress disorder (n ¼ 1). 
Furthermore, seven patients on MPH were also cur-
rently treated with antidepressant medication because 
of comorbid disorders. 
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Healthy individuals 
Furthermore, 96 healthy individuals were assessed. 
Healthy individuals were recruited via public announce-
ments, word-of-mouth and through contacts of the 
researchers involved. None of the healthy individuals 
reported to have a history of neurological or psychiatric 
diseases and none was taking any medication known to 
affect the central nervous system. All healthy individuals 
completed the same self-report questionnaires for cur-
rent and retrospective ADHD symptoms prior to the 
assessment (Rösler et al., 2008). Intellectual functions 
of all participants were measured using the Multiple 
Choice Vocabulary Test (Lehrl, 1995). From the 96 
healthy individuals, 36 individuals were selected accord-
ing to age, sex and intellectual functions in order to 
obtain a group with characteristics which are compara-
ble to the two patient groups. Characteristics of healthy 
individuals and patients with ADHD are presented in 
Table 1. Healthy individuals, adults with ADHD not- 
treated with MPH and adults with ADHD on MPH did 
not differ with regard to age (F(2,100) ¼ 0.004; p ¼ .996), 
gender (χ2(2) ¼ 2.94; p ¼ .230) and intellectual functions 
(F(2,100) ¼ 1.03; p ¼ .362). However, as expected, signifi-
cant group differences were obtained with regard to the 
self-reported symptom severity of both current ADHD 
symptoms (F(2,100) ¼ 78.95; p < .001) and retrospective 
ADHD symptoms (F(2,100) ¼ 124.55; p < .001). Whereas 
the two patient groups did not differ in either current 
symptoms (p ¼ 0.278) or retrospective symptoms 
(p ¼ 0.703), healthy individuals showed significant lower 




Intellectual functions (IQ) were measured using the 
Multiple Choice Vocabulary Test (Lehrl, 1995). The Mul-
tiple Choice Vocabulary Test is a valid and short test 
procedure which provides a measure of intellectual 
functioning. 
Alertness 
Alertness was measured with a computerized test 
from the Testbattery for Attentional Performance 
(Zimmermann & Fimm, 2008). In this test, participants 
were asked to respond as quickly as possible to the 
presentation of a visual stimulus by pressing a specified 
button. The stimulus appeared on the screen either with 
or without prior warning, providing measures of tonic 
and phasic alertness (reaction times). 
Selective attention 
In the Visual Scanning test (Zimmermann & Fimm, 
2008) a series of matrices was presented in the center 
of the computer screen. Participants were asked to press 
a response button as quickly as possible whenever a 
matrix contained a predefined critical stimulus or to 
press another response button if the critical stimulus 
was not contained. The reaction time for correct 
responses of trials which did not contain a critical 
stimulus was registered. 
Vigilance 
In the vigilance test (Zimmermann & Fimm, 2008), a 
sequence of tones was presented to the participant, 
Table 1. Characteristics of healthy individuals, adults with ADHD not-treated with MPH (ADHD Off-MPH), and adults with ADHD 
treated with MPH (ADHD On-MPH).    
Adults with ADHD  
Healthy individuals Off-MPH On-MPH  
M � SD % with impairmentg M � SD % with impairmentg M � SD % with impairmentg  
n 36 36 31 
Descriptive variables 
Age (in years) 34.1 � 10.5 34.1 � 10.9 33.9 � 9.6 
Gender (female/male) 20/16 21/15 12/19 
Intellectual functions (IQ)a 102.9 � 8.2 102.2 � 13.0 105.9 � 12.3 
Comorbidityb – 7 (6/1/0/0/0/0/0) 14 (10/2/3/2/1/1/1) 
Self-reported ADHD symptom severity 
Childhood symptoms (WURS-K)c 10.8 � 7.9 43.7 � 11.6d 45.8 � 11.5d 
Current symptoms (ASR)e 9.3 � 4.2 32.2 � 8.8d 28.9 � 11.0d,f 
Standard measures of cognition 
Alertness – tonic (in msec) 243.0 � 39.4  8.3 279.9 � 59.6d  25.0  249.0 � 37.6h  6.5 
Alertness – phasic (in msec) 240.5 � 35.3  5.6 270.4 � 60.6d  13.9  243.4 � 32.3h  6.5 
Selective attention (in sec) 4.53 � 1.59  5.7 5.72 � 1.53d  25.7  5.04 � 1.43  16.7 
Vigilance (Omissions) 0.94 � 1.29  5.6 2.75 � 3.43d  22.2  1.83 � 3.09  12.9 
Inhibition (Difference score) 26.6 � 10.7  13.9 37.5 � 17.9d  22.2  29.5 � 15.7  16.1 
aMultiple Choice Vocabulary Test (MWT-B); bNumber of patients affected with psychiatric comorbid disorders (some patients affected with more than one): 
mood disorders/personality disorders/anxiety disorders/somatoform disorders/obsessive-compulsive disorder/substance abuse in the past/posttraumatic 
stress disorder; cWender Utah Rating Scale – short version; dp < .05 when compared to healthy individuals; eADHD Self-Report Scale; fPatients with 
ADHD treated with MPH were instructed to refer to typical situations when not being treated with MPH and to rate the severity of experienced ADHD 
symptoms in these situations; gImpaired on a specific test if scored within the lowest 10%  of scores of control participants (n ¼ 96); hp < .05 when 
compared to adults with ADHD Off-MPH.    
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whereas two different types of tones could be dis-
tinguished, one with a high pitch and the other with a 
low pitch. The two types of tones were presented alter-
nately in a constant rhythm. A target event was defined 
if two tones of the same pitch were directly presented 
after each other. The participant was requested to press 
a specified response button as quickly as possible if a 
target event occurred. The total duration of the vigilance 
test was 30 minutes. The number of omissions was 
registered as a measure of vigilance. 
Inhibition 
Inhibition was measured with the Stroop Color-Word 
Interference test (Bäumler, 1985; Stroop, 1935) which 
consisted of three conditions. In the Color Word con-
dition, color words (YELLOW, GREEN, BLUE, and 
RED) printed in black ink were presented on a card 
and participants were required to read them as fast as 
possible. In the Color Block condition, colored rectan-
gles (rectangles printed in yellow, green, blue, and 
red) were presented on a card and participants were 
required to name the color of the rectangles as fast as 
possible. In the Color-Word Interference condition, 
color words (YELLOW, GREEN, BLUE, and RED) were 
presented and printed in mismatching ink (e.g., RED 
printed in blue ink). The participants were required to 
state the color of the ink as fast as possible and to ignore 
the meaning of the printed word. The time in seconds to 
complete each trial was registered. As dependent vari-
able, a difference score was calculated by subtracting 
the time needed for completion of the Color Block con-
dition from the Color-Word Interference condition 
(Boonstra et al., 2005). 
Short-term memory 
The Digit Span Forward of the Wechsler Memory Scale 
(Wechsler, 1987) was applied as a measure of short- 
term memory. Series of numbers were read to the part-
icipants who were required to repeat the digits in the 
same order as presented. Subsequent series of numbers 
increased in length. The total number of correctly 
repeated sequences was registered. 
Working memory 
The Digit Span Backward (Wechsler, 1987) was per-
formed to measure working memory. Series of numbers 
were read to the participants who were required to 
repeat the digits in reversed order. Subsequent series 
of numbers increased in length. The total number of 
correctly repeated sequences was registered. 
Immediate and delayed story recall 
Immediate and delayed story recall was assessed with 
the Logical Memory I and II (Wechsler, 1987). Two 
short stories were read out to the participants by the 
experimenter. Participants were required to listen to 
the stories and to recall immediately and after a delay 
of about 20 minutes as many details as possible. The 
number of correctly recalled details was registered for 
the immediate and delayed story recall. 
Immediate word recognition 
A word list paradigm was used in order to test immedi-
ate word recognition (Fuermaier, Tucha, Koerts, 
Aschenbrenner, Weisbrod, et al., 2013). In the study 
phase of the immediate word recognition test, 40 unre-
lated nouns were presented consecutively for four sec-
onds in the center of a computer screen. Participants 
were instructed to focus on the stimulus presentation 
and to use whatever mnemonics they thought were 
effective to memorize the words presented on the 
screen. A recognition test was performed immediately 
after the study phase. In the recognition test, all words 
from the study list as well as 40 additional words were 
presented consecutively in random order. The parti-
cipants were instructed to indicate by pressing one of 
two predefined buttons whether the displayed word 
has been presented in the study phase or not. The num-
ber of correctly classified words was registered. 
Delayed word recognition and retention 
A word list paradigm was applied in order to test 
delayed word recognition (Fuermaier, Tucha, Koerts, 
Aschenbrenner, Weisbrod, et al., 2013). In the study 
phase of the delayed word recognition test, 40 unrelated 
nouns were again presented consecutively for four 
seconds. Participants were instructed to focus on the 
stimulus presentation and to use whatever mnemonics 
they thought were effective. A delay of 40 minutes fol-
lowed the study phase. After the delay, a recognition test 
was performed and all words from the study phase and 
the distractor list which have not been presented before 
were presented consecutively in random order. The 
participants were instructed to indicate by pressing 
one of two predefined buttons whether the displayed 
word has been presented in the study phase or not. 
The number of correctly classified words was registered 
for the measure of delayed word recognition. Moreover, 
a measure of retention was obtained by calculating the 
quotient of the number of correctly classified words in 
the delayed word recognition test divided by the num-
ber of correctly classified words in the immediate word 
recognition test (as discussed previously). 
Source memory 
A source discrimination paradigm was applied to 
examine performance in source memory (Fuermaier, 
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Tucha, Koerts, Aschenbrenner, Weisbrod, et al., 2013). 
Twenty-eight unrelated German nouns were presented 
consecutively on a screen. Half of the words were dis-
played in blue font on the left hand side of a screen 
and the other half of the words were presented in green 
font on the right hand side. Each word appeared for 
seven seconds on the screen. The participants were 
instructed to focus on the stimulus presentation and 
to use whatever mnemonics they thought were effective 
to memorize the words AND the corresponding source of 
the words (blue font on the left side or green font on the 
right side). The source discrimination task was per-
formed immediately after the study phase. All 28 words 
were presented in consecutive order, displayed in 
black font in the center of the screen. The participants 
were instructed to indicate where/how the word has 
been presented in the study phase, i.e., in blue font on 
the left side or in green font on the right side. The 
response was given by pressing one of two predefined 
buttons. The number of correctly classified words was 
registered. 
Prospective memory 
A planning task requiring delayed task execution was per-
formed as a measure of prospective memory (Fuermaier, 
Tucha, Koerts, Aschenbrenner, Westermann, et al., 
2013). In the present task, 10 subtests were introduced, 
grouped in five pairs of subtests, including arithmetic 
problems, cancellations tests, wording findings, screwing 
tests, and ball squeezing tests. Participants were asked to 
plan and, after a delay of about 60 minutes, to carry out 
these 10 subtests in a limited period of time under the 
consideration of certain rules. The rules of the present 
task included (a) a restriction in time (10 minutes), (b) 
a restriction in the sequence in which the subtests can 
be performed, (c) the possibility to perform two subtests 
simultaneously, and (d) the instruction to work on each 
of the 10 subtests at least once for a short period of time. 
In this task, several components of complex prospective 
memory can be distinguished, i.e., planning, recall, 
self-initiation, and execution. However, general task per-
formance is indicated by a measure of switching between 
subtests (task switching). Task switching is calculated by 
the sum of actually initiated subtests at task execution 
under consideration of the rules. Task switching is crucial 
and may indicate general task performance since success-
ful execution of the task requires active switching 
between subtests. Therefore, the number of initiated 
subtests at task execution was suggested as the primary 
measure for prospective memory (for details of the task 
performed, see Fuermaier, Tucha, Koerts, Aschenbren-
ner, Westermann, et al., 2013). However, considering that 
there is only one possibility to initiate the delayed 
intention, it must be noted that the reliability of such sin-
gle, one-time prospective memory tasks may be 
questionable. 
Procedure 
All participants were tested individually and received no 
reward for participation. Participants gave written 
informed consent at the beginning of the experiment. 
Subsequently, the neuropsychological assessment was 
performed, administered in two parts separated by a 
break to recover from possible fatigue. In the first part, 
tests for immediate word recognition, delayed word rec-
ognition and source memory were conducted. The 
order of the immediate word recognition test and the 
delayed word recognition test was counterbalanced 
across participants in order to control for learning 
and interference effects. The vigilance test was conduc-
ted between word list presentation and word recog-
nition of the delayed word recognition test. After a 
short break, immediate and delayed story recall was per-
formed to minimize interference with verbal learning 
tasks (i.e., word recognition test) of the first part of 
the assessment. Standard measures of cognition (i.e., 
tests for alertness, selective attention, and inhibition) 
were performed between immediate story recall and 
delayed story recall. All participants were debriefed at 
the end of the assessment. The total duration of the 
assessment was about two hours. 
Ethics statement 
The study was conducted in compliance with the 
Helsinki Declaration. Ethical approval was obtained by 
the ethics committee of the medical faculty of the 
University of Heidelberg, Germany. 
Statistical analysis 
Multivariate analyses of variance (MANOVA) were 
applied to compare cognitive functions of patients with 
ADHD treated with MPH, patients with ADHD not- 
treated with MPH and healthy individuals. MANOVA 
was performed twice in order to compare performance 
in attention and memory in separate analyses. The 
categorical variable of self-initiation in the prospective 
memory task was analyzed using chi-square test. Stat-
istical significance of differences was calculated for each 
multivariate comparison (memory and attention) as 
well as for each dependent variable. Pairwise group 
comparisons were performed calculating Scheffé post- 
hoc analysis for each dependent variable. Furthermore, 
effect sizes (g2, Cohen’s d) were calculated for all 
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comparisons. The index g2 provides information about 
the proportion of variance which is accounted for by 
the factor group membership (three levels) in multivari-
ate analyses. As described by Cohen (1988), g2 is a func-
tion of the effect size index f. According to Cohen, a 
small effect size (f ¼ .10) corresponds to an g2 ¼ .0099, 
a medium effect size (f ¼ .25) to an g2 ¼ .0588 and a 
large effect size (f ¼ .40) to an g2 ¼ .1379. The effect size 
d was computed for all pairwise comparisons of means. 
According to Cohen, negligible effects (d < 0.20), small 
effects (0.20 � d < 0.50), medium effects (0.50 � d 
< 0.80) and large effects (d ≥ 0.80) were distinguished. 
A significance level of a ¼ .05 was set for all tests. How-
ever, memory functions were compared between groups 
on multiple variables (different aspects of memory), 
which results in a-error accumulation. Interpretation 
of results was therefore also very much based on effect 
sizes. Furthermore, the number of participants with 
impairments in each of the functions assessed was 
determined. This was achieved by classifying the parti-
cipants’ test scores on the basis of a commonly accepted 
categorization of ability levels (Lezak, Howieson, & 
Loring, 2004). Test scores lower than the “low-average” 
values (i.e., percentile �10) were individually classified 
as impaired. The percentiles of patients’ test scores were 
calculated on the basis of test scores of a control sample 
(n ¼ 96) with comparable characteristics with regard to 
age, gender, and intellectual functions. Data analysis 
was performed using SPSS 20 for Windows. 
Results 
Attention performance of participants 
MANOVA indicated a significant difference of medium 
size in attention performance between groups (Wilk’s 
lambda ¼ 0.759, F(10,186) ¼ 2.75, p ¼ .003, g2 ¼ .129). 
Significant group differences of medium size were 
found on all measures of attention, including tonic alert-
ness (F(2,97) ¼ 6.43, p ¼ .002, g2 ¼ .117), phasic alertness 
(F(2,97) ¼ 5.10, p ¼ .008, g2 ¼ .095), selective attention 
(F(2,97) ¼ 5.37, p ¼ .006, g2 ¼ .100), vigilance (F(2,97) ¼
3.20, p ¼ .045, g2 ¼ .062), and inhibition (F(2,97) ¼ 4.82, 
p ¼ .010, g2 ¼ .090). Post-hoc analysis revealed a signifi-
cant decreased performance of patients with ADHD 
not-treated with MPH when compared to healthy indivi-
duals in all measures of attention, that is, tonic alertness 
(p ¼ .005, d ¼ 0.73), phasic alertness (p ¼ .017, d ¼ 0.59), 
selective attention (p ¼ .006, d ¼ 0.76), vigilance 
(p ¼ .047, d ¼ 0.70), and inhibition (p ¼ .012, d ¼ 0.75). 
All differences were of medium size. Patients with 
ADHD treated with MPH did not differ significantly 
from healthy individuals in all measures, as also indicated 
by negligible to small effects (tonic alertness: p ¼ .865, 
d ¼ 0.16; phasic alertness: p ¼ .969, d ¼ 0.06; selective 
attention: p ¼ .403, d ¼ 0.34; vigilance: p ¼ .356, d ¼ 0.38; 
inhibition: p ¼ .669, d ¼ 0.22). The comparison of patient 
groups revealed that patients on medication showed a 
significantly increased performance of medium size in 
tonic alertness (p ¼ .030, d ¼ 0.61) and phasic alertness 
(p ¼ .043, d ¼ 0.54), whereas small non-significant 
differences were found on the remaining measures 
(selective attention: p ¼ .208, d ¼ 0.46; vigilance: p ¼ .626, 
d ¼ 0.28; inhibition: p ¼ .136, d ¼ 0.47). Table 1 presents 
participants’ test scores as well the proportion of indivi-
duals with impairments in each of the attentional 
functions assessed. 
Memory performance of participants 
MANOVA indicated a significant difference of large 
size in memory functions between groups (Wilk’s 
lambda ¼ 0.425, F(26,176) ¼ 3.61, p < .001, g2 ¼ .348). 
Significant group differences were found on measures 
of short term memory (F(2,100) ¼ 4.76; p ¼ .011; 
g2 ¼ .087), retrospective memory (immediate word rec-
ognition: F(2,100) ¼ 4.01; p ¼ .021, g2 ¼ .074; immediate 
story recall: F(2,100) ¼ 12.90; p < .001; g2 ¼ .205; 
delayed story recall: F(2,100) ¼ 8.14; p < .001; 
g2 ¼ .140), and prospective memory (general perfor-
mance: F(2,100) ¼ 12.67; p < .001; g2 ¼ .202; planning: 
F(2,100) ¼ 15.51; p < .001; g2 ¼ .237). Effects were of 
medium to large size. Group means, post-hoc pairwise 
comparisons, as well the proportion of individuals with 
impairments in each of the memory functions are pre-
sented in Table 2. Patients with ADHD not-treated with 
MPH showed a significantly decreased performance as 
compared to control participants in short-term memory 
(p ¼ .047), immediate word recognition (p ¼ .021), 
immediate story recall (p < .001), delayed story recall 
(p ¼ .004), and prospective memory (general task per-
formance (p < .001) and planning (p < .001)). Patients 
with ADHD on MPH displayed a significantly poorer 
performance than control participants in immediate 
story recall (p < .001), delayed story recall (p ¼ .003), 
as well as both general task performance (p < .001) 
and planning (p ¼ .019) of the prospective memory task. 
A comparison of patient groups revealed that patients 
on MPH performed significantly better regarding 
short-term memory (p ¼ .023) and planning as assessed 
in the prospective memory task (p ¼ .048) than patients 
off MPH. Table 3 presents effect sizes of pair-wise group 
comparisons (Cohen’s d). However, negligible to small 
non-significant effects were found on the remaining 
measures of memory functions, including working 
memory (F(2,100) ¼ 0.36; p ¼ .697; g2 ¼ .007), delayed 
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word recognition (F(2,100) ¼ 1.47; p ¼ .235; g2 ¼ .029), 
source memory (F(2,100) ¼ 2.97; p ¼ .056; g2 ¼ .056), 
and prospective memory (i.e., recall: F(2,100) ¼ 0.64; 
p ¼ .527; g2 ¼ .013; initiation: χ2(2) ¼ 1.333; p ¼ .513; 
execution: F(2,100) ¼ 2.88; p ¼ .061; g2 ¼ .054; Table 2 
and 3). 
Discussion 
The results of the present study emphasize the severity 
of memory impairments of adults with ADHD. Non- 
medicated patients with ADHD were found to have 
large impairments on multiple aspects of memory which 
exceeded their impairments of attention in severity 
(impairments of attention were of medium size). The 
severity of memory impairments of adults with ADHD 
were also stressed in previous studies on neuropsycho-
logical functions of patients with ADHD (Altgassen, 
Kretschmer et al., 2014; Muir-Broaddus et al., 2002; 
Seidman et al., 1998) and can presumably be explained 
by the high demand of these memory functions on 
executive control. Contrary to our expectations, how-
ever, intact abilities of adults with ADHD were found 
in working memory. This appears surprising in the light 
Table 2. Memory performance (M � SD) of healthy individuals, adults with ADHD not-treated with MPH (ADHD Off-MPH), and adults 
with ADHD treated with MPH (ADHD On-MPH).    
Adults with ADHD  
Healthy individuals Off-MPH On-MPH  
M � SD % with impairmenta M � SD % with impairmenta M � SD % with impairmenta  
Short-term memory 
Digit span forward (score)  7.9 � 1.9  11.1  6.9 � 1.7b  22.2  8.1 � 1.7c  6.5 
Working memory 
Digit span backward (score)  6.6 � 1.9  11.1  6.5 � 2.0  13.9  6.3 � 1.6  9.7 
Retrospective memory 
Immediate 
Word recognition (% recognized)  84.6 � 9.8  2.8  77.1 � 13.4b  27.8  81.2 � 9.8  6.5 
Story recall (sum score)  30.8 � 5.9  11.1  24.1 � 7.2b  58.3  24.0 � 6.2b  58.1 
Delayed 
Word recognition (% recognized)  72.7 � 11.9  5.6  68.7 � 10.4  13.9  72.7 � 11.5  3.2 
Story recall (sum score)  26.6 � 6.9  16.7  20.8 � 7.9b  50.0  20.3 � 6.8b  41.9 
Retention (in %)  86.2 � 11.6  13.9  90.4 � 12.7  8.3  89.7 � 10.6  3.2 
Source memory 
Source discrimination (% classified)  78.1 � 14.8  5.6  69.2 � 15.8  27.8  73.6 � 15.8  19.4 
Prospective memory 
General performance (switching score)  11.3 � 6.6  19.4  6.1 � 3.9b  52.8  6.2 � 3.5b  61.3 
Planning (score)  19.6 � 5.1  8.3  11.7 � 5.8b  52.8  15.4 � 7.0b,c  41.9 
Recall (% correctly recalled)  88.4 � 15.9  8.3  86.5 � 22.0  19.4  91.4 � 12.4  3.2 
Initiation (% of participants initiated)  0.53 � 0.51  –  0.47 � 0.51  –  0.61 � 0.50  – 
Execution (% executed)  70.2 � 24.4  22.2  55.6 � 25.7  41.7  63.8 � 27.6  25.8 
aImpaired on a specific test if scored within the lowest 10% of scores of control participants (n ¼ 96); bp < .05 when compared to healthy individuals; cp < .05 
when compared to adults with ADHD Off-MPH.    
Table 3. Effect sizes (Cohen’s d) of group differences between healthy individuals, adults with ADHD not-treated with MPH (ADHD 
Off-MPH), and adults with ADHD treated with MPH (ADHD On-MPH).  
Healthy individuals vs.  
ADHD Off-MPH 
Healthy individuals vs.  
ADHD On-MPH 
ADHD Off-MPH vs.  
ADHD On-MPH  
Short-term memory 
Digit span forward (score)  0.56  0.11  0.71 
Working memory 
Digit span backward (score)  0.05  0.17  0.11 
Retrospective memory 
Immediate 
Word recognition (% recognized)  0.64  0.35  0.35 
Story recall (sum score)  1.02  1.13  0.02 
Delayed 
Word recognition (% recognized)  0.36  0.00  0.37 
Story recall (sum score)  0.78  0.92  0.07 
Retention (in %)  0.35  0.31  0.06 
Source memory 
Source discrimination (% classified)  0.59  0.30  0.28 
Prospective memory 
General performance (switching)  0.96  0.95  0.03 
Planning (score)  1.45  0.69  0.58 
Recall (% correctly recalled)  0.10  0.10  0.27 
Initiation (% of participants)  0.12  0.16  0.28 
Execution (% executed)  0.58  0.25  0.31  
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of the relatively robust findings indicating working 
memory deficits in ADHD as reported in meta-analyses 
on both children (Willcutt et al., 2005) and adults with 
ADHD (Alderson, Kasper, Hudec, & Patros, 2013; 
Schoechlin & Engel, 2005). Considering the large variety 
of paradigms used to assess working memory, it is also 
worth noting that there are studies available showing 
working memory deficits of adults with ADHD on the 
same task (Digit Span Backward) as used in the present 
study (Barkley, Murphy, & Kwasnik, 1996; Murphy, 
Barkley, & Bush, 2001). Furthermore, neuroimaging 
studies stressed the importance of lateral prefrontal 
brain regions for intact working memory in healthy 
adults (Cabeza & Nyberg, 2000) and also demonstrated 
a link between decreased working memory performance 
of adults with ADHD and decreased activation in these 
brain areas (Cubillo & Rubia, 2010). However, even 
though working memory deficits seem to be very 
prominent among adults with ADHD, it has been noted 
that these deficits are not universal (Alderson et al., 
2013) and are thus neither necessary nor sufficient to 
cause ADHD (Willcutt et al., 2005) but should rather 
be seen as an important component of the complex 
neuropsychology of ADHD. 
Comparing memory performance between adults 
with ADHD treated and not-treated with MPH, it was 
found that individual tailored and clinical appropriate 
doses of MPH improved memory performance of 
patients, that is, short-term memory, word recognition, 
source memory and prospective memory. However, 
adults with ADHD treated with MPH still showed con-
siderable memory impairments when compared to a 
normal level of functioning, as it was revealed by large 
impairments in story recall and prospective memory. 
This is in agreement with findings of previous studies 
exploring effects of MPH on cognition in patients with 
ADHD, showing that MPH improves cognition 
of adults with ADHD, but does not necessarily normal-
ize their level of performance (O. Tucha, Mecklinger 
et al., 2006, L. Tucha et al., 2011). Beneficial effects of 
stimulant medication on memory functions have also 
been observed in children with ADHD (e.g., Bedard et 
al., 2004; Rhodes et al., 2005); however, there are also 
clear indications that drug treatment does not necessar-
ily normalize memory functioning of children with 
ADHD (Gualtieri & Johnson, 2008). The importance 
of a treatment of these impairments is underlined by 
findings showing the adverse consequences of cognitive 
impairments on the patients’ daily life. For example, a 
recently published study demonstrated that adults with 
ADHD are aware of multiple cognitive deficits and per-
ceive large impairments in various situations of daily life 
requiring cognitive functions (Fuermaier et al., 2014). 
These experienced impairments do not only refer to 
situations associated with attention and executive func-
tions, but also to situations requiring retrospective and 
prospective memory. Further improvement of memory 
functions of adults with ADHD on MPH might 
be achieved by combining the pharmacological inter-
vention with psychosocial intervention strategies (i.e., 
cognitive-behavioral therapy [CBT]). Psychosocial 
intervention programs (such as CBT) were shown to 
effectively improve symptoms and executive skills of 
adults with ADHD (Solanto, Marks, Mitchell, 
Wasserstein, & Kofman, 2008; Solanto et al., 2010; 
Vidal-Estrada et al., 2012). A combination of both phar-
macological and behavioral treatments is therefore sug-
gested and widely regarded as the gold standard for the 
treatment of adults with ADHD (Rostain & Ramsay, 
2006; Vidal-Estrada et al., 2012; S. B. Wigal, 2009). 
Furthermore, implications can be drawn with regard 
to the sensitivity of neuropsychological tests in measur-
ing effects of MPH treatment on cognition in adults 
with ADHD. An exploration of the size of differences 
(effect sizes) between patients on and off MPH indicates 
that the improvements were considerably larger on 
measures of attention than on measures of memory. 
This was demonstrated by performance differences on 
measures of attention which were up to medium size, 
whereas no meaningful changes were found in story 
recall and only small effects in word recognition. With 
regard to prospective memory, a difference between 
patient groups of medium size was only revealed by 
the planning task, supporting the notion that in parti-
cular measures related to attention/executive functions 
are sensitive to the effects of MPH on cognition of 
patients with ADHD. This notion is also supported by 
findings of previous research showing that pharmaco-
logical treatment with MPH resulted in substantial 
improvements of attention and planning skills of adults 
with ADHD (Coghill et al., 2013; Tucha, Prell, et al., 
2006; Turner et al., 2005). It still remains unsolved 
why considerably smaller effects were found on mea-
sures of memory as compared to measures of atten-
tion/executive functions. As a possible explanation, it 
can be speculated that treatment with MPH improves 
basic cognitive functions, such as attentional function-
ing. The pharmacological induced improvements of 
these basic functions are, of course, also beneficial for 
various other functions that rely on these more basic 
functions, such as memory operations. The finding that 
the observed impact on memory functioning was con-
siderably smaller might indicate that adults with ADHD 
could benefit from instructions and trainings focusing 
on how to effectively apply their heightened cognitive 
abilities. On the basis of the present data, it can be 
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concluded that a routine neuropsychological assessment 
of adults with ADHD is sensitive in showing the 
efficiency of MPH treatment in the majority of patients, 
with tests of attention and executive functions appear-
ing more suited than memory tests. 
Nevertheless, the value of the present results is lim-
ited since reliable conclusions on the effects of MPH 
are difficult to draw due to the constraints associated 
with a between-subject design as performed in this 
study. Even though the two patient groups (on and off 
MPH) were similar with regard to a range of character-
istics (e.g., age, gender, intellectual functions and 
ADHD symptom severity), other characteristics differed 
between groups such as the distribution of ADHD sub-
type, comorbidity, or pharmacological treatment with 
antidepressant medication. Furthermore, it must be 
noted that self-reported symptom-severity of patients 
treated with MPH may not have been reliably assessed 
as they may have over- or underestimate their symp-
toms when not being treated, depending on for how 
long they have been on MPH. The observed differences 
in memory functioning attributed to pharmacological 
treatment could therefore also be caused by other fac-
tors. With regard to the effects of antidepressant medi-
cation, an explorative analysis of the present data did 
neither reveal a significant difference in measures of 
attention nor in measures of memory between patients 
treated and not-treated with antidepressant medication 
(data not shown). However, sample size of patients 
treated with antidepressant medication was small and 
does therefore not allow a reliable analysis. The 
approach of the present study, however, had also an 
advantage over the application of a repeated measure 
design by avoiding practice or carry-over effects occur-
ring when participants are assessed repeatedly. 
In conclusion, the present study is the first to 
provide evidence about the beneficial effects of MPH 
treatment on a range of memory functions of adults 
with ADHD. The findings reported, however, need to 
be replicated in future studies by applying more 
controlled study designs, that is, a repeated measure, 
placebo-controlled, cross-over design. Further evidence 
for the effectiveness for stimulant drug treatment could 
be derived from neuroimaging studies. In this respect, 
functional neuroimaging studies revealed an associ-
ation between decreased brain activation in fronto- 
striatal and fronto-cerebellar areas of patients with 
ADHD and decreased performance in tasks assessing 
cognitive control (Durston & Konrad, 2007; Valera 
et al., 2005). Therefore, It would be desirable if treat-
ment studies would be combined with the application 
of neuroimaging techniques in order to explore the 
association between behavioral changes (i.e., improved 
memory functions) and changes of brain activation, 
particularly in regions in which abnormal activation 
patterns have been found in patients with ADHD 
(Cubillo, Halari, Smith, Taylor, & Rubia, 2009; Cubillo 
& Rubia, 2010). 
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